Low-dose erythropoietin optimizes hemoglobin levels in anemic arthroplasty patients, suggesting effective blood management strategies.
Within a contemporary PBM framework, selective low-dose preoperative EPO safely optimized perioperative Hb levels and was associated with a transfusion-free perioperative course despite higher baseline hematologic risk. These findings suggest that modern low-transfusion PBM strategies can be effectively extended to selected anemic arthroplasty patients by improving preoperative Hb reserve.
No takes yet. Share an insight, caveat, or question.
Hourlier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: